Literature DB >> 19609291

Bingchamides A and B, two novel cyclic pentapeptides from the Streptomyces bingchenggensis: fermentation, isolation, structure elucidation and biological properties.

Wen-Sheng Xiang1, Ji-Dong Wang, Xiang-Jing Wang, Ji Zhang.   

Abstract

Two novel cyclic pentapeptides, bingchamides A (1) and B (2), have been isolated from the organic extracts of the mycelium of Streptomyces bingchenggensis. The structures of 1 and 2 were elucidated on the basis of extensive 1D and 2D NMR, as well as HRESI-MS, electrospray ionization-MS, UV and IR spectroscopic data analysis. Bingchamides A (1) and B (2) exhibited in vitro cytotoxicity toward human colon carcinoma cell line HCT-116 with the IC(50) values of 14.1 and 18.0 microg ml(-1), respectively. The bingchamides A (1) and B (2) scaffolds are probably promising structures for the development of new antitumor agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609291     DOI: 10.1038/ja.2009.60

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Unveiling Concealed Functions of Endosymbiotic Bacteria Harbored in the Ascomycete Stachylidium bicolor.

Authors:  Celso Almeida; Cristina Silva Pereira; Victor Gonzalez-Menendez; Gerald Bills; Javier Pascual; Marina Sánchez-Hidalgo; Stefan Kehraus; Olga Genilloud
Journal:  Appl Environ Microbiol       Date:  2018-07-17       Impact factor: 4.792

2.  Synthesis of endolides A and B: naturally occurring N-methylated cyclic tetrapeptides.

Authors:  Emma K Davison; Alan J Cameron; Paul W R Harris; Margaret A Brimble
Journal:  Medchemcomm       Date:  2019-03-05       Impact factor: 3.597

3.  Genome sequence of the milbemycin-producing bacterium Streptomyces bingchenggensis.

Authors:  Xiang-Jing Wang; Yi-Jun Yan; Bo Zhang; Jing An; Ji-Jia Wang; Jun Tian; Ling Jiang; Yi-Hua Chen; Sheng-Xiong Huang; Min Yin; Ji Zhang; Ai-Li Gao; Chong-Xi Liu; Zhao-Xiang Zhu; Wen-Sheng Xiang
Journal:  J Bacteriol       Date:  2010-06-25       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.